Vivet Therapeutics Alternatives & Competitors
12 companies similar to Vivet Therapeutics — Vivet Therapeutics develops gene therapy treatments for inherited liver disorder...
bluebird bio
Pursuing curative gene therapies to give patients and their families more bluebird days.
Somerville, United States
Beam Therapeutics
Our vision is to provide life-long cures for patients suffering from serious diseases.
Cambridge, United States
BridgeBio
We move at the speed of patient need.
Palo Alto, United States
Prevail Therapeutics
Wholly owned subsidiary of Eli Lilly and Company
New York, United States
Track all Vivet Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Rocket Pharmaceuticals
Seeking gene therapy cures
Cranbury, United States
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Affinia Therapeutics
Building the next generation of gene therapies
Waltham, United States
Variantyx
Variantyx is a technology-driven precision medicine company providing state-of-the-art gen...
Framingham, United States
Portola Pharmaceuticals
South San Francisco, Unit...
Bluejay Therapeutics
Developing innovative cures for infectious diseases with the first target indication of ch...
United States
Ascidian Therapeutics
Rewriting RNA
Boston, United States
About Vivet Therapeutics
Vivet Therapeutics develops gene therapy treatments for inherited liver disorders using liver tropic virus.
Development of transformative gene therapies, AAV-based therapeutic technologies, Research and clinical trials focused on rare diseases, Patient advocacy and support in rare genetic disorders
Patients with rare genetic disorders, Healthcare professionals in gene therapy, Biotechnology partners, Investors in healthcare and biotechnology sectors
Gene Therapy, Inherited Liver Disorders, Orphan Diseases, Liver Tropic Virus, AAV Vectors, Liver Targeting, Gene Delivery Optimization, Long-term Expression, Collaborative Research, Biotechnology Innovation, Medical Research Partnership
B2B, B2D
Licensing, Performance Based, Project Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Vivet Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Vivet Therapeutics on 11 Mar 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.